Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review

The monkeypox disease is a zoonotic-infectious disease that transmits between animals and humans. It is caused by a double-stranded DNA virus belonging to the Orthopoxvirus genus that is closely related to the variola virus –the causative agent of smallpox. Although monkeypox infections were endemic...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Vaccines
المؤلف الرئيسي: 2-s2.0-85144741230
التنسيق: Review
اللغة:English
منشور في: MDPI 2022
الوصول للمادة أونلاين:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85144741230&doi=10.3390%2fvaccines10122091&partnerID=40&md5=a6d47e5662aa88a8f8a6a15ed7592e41
id Saied A.A.; Dhawan M.; Metwally A.A.; Fahrni M.L.; Choudhary P.; Choudhary O.P.
spelling Saied A.A.; Dhawan M.; Metwally A.A.; Fahrni M.L.; Choudhary P.; Choudhary O.P.
2-s2.0-85144741230
Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
2022
Vaccines
10
12
10.3390/vaccines10122091
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85144741230&doi=10.3390%2fvaccines10122091&partnerID=40&md5=a6d47e5662aa88a8f8a6a15ed7592e41
The monkeypox disease is a zoonotic-infectious disease that transmits between animals and humans. It is caused by a double-stranded DNA virus belonging to the Orthopoxvirus genus that is closely related to the variola virus –the causative agent of smallpox. Although monkeypox infections were endemic to Western and Central Africa, the newly emerging monkeypox outbreak spread to more than 90 non-African countries. With the exception of the PCR-confirmed case of a return from Nigeria to the United Kingdom, the ongoing outbreak is largely unrelated to travel. In the most recent wave, cases are characteristically males in their thirties. Risk factors include close and particularly sexual contact with an infected person, and contact with fomites, infected animals or aerosolized-infectious material. Clinical diagnosis of monkeypox is confirmed with nucleic-acid amplification testing of samples originating from vesicles or genital lesions and using real-time or conventional PCR. Other methods, such as electron microscopy, immunohistochemistry, and virus culture are costly and time-consuming. In addition to timely diagnosis and contact tracing, restrictive measures to limit spread, such as isolation of infected patients, preventing contact with wild animals, and isolation of animals suspected to be viral reservoirs have shown promise. Although there are no specific treatments for monkeypox disease, the experience with smallpox suggests that the vaccinia vaccine, cidofovir, tecovirimat, and vaccinia immune globulin (IVG) may be beneficial for monkeypox treatment. In this review, we provide an update on the human-monkeypox disease with a special emphasis on its pathogenesis, prevention, diagnostics, and therapeutic measures. © 2022 by the authors.
MDPI
2076393X
English
Review
All Open Access; Gold Open Access; Green Open Access
author 2-s2.0-85144741230
spellingShingle 2-s2.0-85144741230
Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
author_facet 2-s2.0-85144741230
author_sort 2-s2.0-85144741230
title Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
title_short Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
title_full Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
title_fullStr Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
title_full_unstemmed Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
title_sort Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review
publishDate 2022
container_title Vaccines
container_volume 10
container_issue 12
doi_str_mv 10.3390/vaccines10122091
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85144741230&doi=10.3390%2fvaccines10122091&partnerID=40&md5=a6d47e5662aa88a8f8a6a15ed7592e41
description The monkeypox disease is a zoonotic-infectious disease that transmits between animals and humans. It is caused by a double-stranded DNA virus belonging to the Orthopoxvirus genus that is closely related to the variola virus –the causative agent of smallpox. Although monkeypox infections were endemic to Western and Central Africa, the newly emerging monkeypox outbreak spread to more than 90 non-African countries. With the exception of the PCR-confirmed case of a return from Nigeria to the United Kingdom, the ongoing outbreak is largely unrelated to travel. In the most recent wave, cases are characteristically males in their thirties. Risk factors include close and particularly sexual contact with an infected person, and contact with fomites, infected animals or aerosolized-infectious material. Clinical diagnosis of monkeypox is confirmed with nucleic-acid amplification testing of samples originating from vesicles or genital lesions and using real-time or conventional PCR. Other methods, such as electron microscopy, immunohistochemistry, and virus culture are costly and time-consuming. In addition to timely diagnosis and contact tracing, restrictive measures to limit spread, such as isolation of infected patients, preventing contact with wild animals, and isolation of animals suspected to be viral reservoirs have shown promise. Although there are no specific treatments for monkeypox disease, the experience with smallpox suggests that the vaccinia vaccine, cidofovir, tecovirimat, and vaccinia immune globulin (IVG) may be beneficial for monkeypox treatment. In this review, we provide an update on the human-monkeypox disease with a special emphasis on its pathogenesis, prevention, diagnostics, and therapeutic measures. © 2022 by the authors.
publisher MDPI
issn 2076393X
language English
format Review
accesstype All Open Access; Gold Open Access; Green Open Access
record_format scopus
collection Scopus
_version_ 1828987867066531840